COVID-19: The Front Line. Challenges in treating high risk ACS cases in the COVID-19 era; a tale of a late infarct.
Optima Education
321 videos
At Optima Education we believe that medical education can be better. Technology is changing and with it the way that we learn. We believe that ideas, concepts and techniques can, and should, be...
Read More
At Optima Education we believe that medical education can be better. Technology is changing and with it the way that we learn. We believe that ideas, concepts and techniques can, and should, be expressed more clearly. We believe that learning is quicker, with more information being retained when it is presented in the correct way.
Speakers
James Spratt Professor of Interventional cardiology with a sub-speciality interest in complex PCI, intravascular...
James Spratt Professor of Interventional cardiology with a sub-speciality interest in complex PCI, intravascular imaging and CTO. He is widely published within this area and has performed live case demonstrations globally. He has an interest in medical education and is the Founder of Optima Education.
Dr Vasileios Panoulas is a Consultant Interventional Cardiologist at the Royal Brompton and Harefield hospitals, part...
Dr Vasileios Panoulas is a Consultant Interventional Cardiologist at the Royal Brompton and Harefield hospitals, part of the Guys and St Thomas NHS Foundation Trust and Honorary Senior Clinical Lecturer at Imperial College London. He has clinical expertise that encompasses both general and interventional cardiology. He is a high volume PCI and TAVI (trans catheter aortic valve implantation) operator with interest in complex high risk PCI and use of mechanical circulatory support (MCS) in patients with cardiogenic shock. Dr Panoulas' research interests involve clinical outcomes with new generation TAVI devices, use of MCS in patients presenting with cardiogenic shock, management of acute coronary syndromes (ACS) and hypertension. Other interests include speckle tracking and hand-held echocardiography and cardiovascular disease in patients with rheumatoid arthritis.
Start a conversation